Genomenon Named GenomeWeb Best Place to Work for Second Consecutive Year

This latest GenomeWeb win reinforces Genomenon’s position as the employer of choice for high-impact genomic talent.

‍

ANN ARBOR, MICH. - November 19, 2025 - FOR IMMEDIATE RELEASE

‍

In a market where world-class talent is the only durable advantage, Genomenon®, Inc. today announced that it has been named one of GenomeWeb’s Best Places to Work for the second year in a row in the 51-100 employee category.

‍

This “two-peat” recognition is based on direct employee feedback and positions Genomenon as a destination of choice for scarce genomic, data science, and commercial talent, reinforcing the company’s ability to execute on its genomic intelligence and literature-derived real-world evidence (RWE) strategy.

‍

“We are so grateful that Genomenon has been recognized again because of our commitment to building a culture where people feel seen, valued, and connected to meaningful work,” said Erin McCann, the company’s head of people. “Our mission is a powerful motivator, and we make sure every role ties back to that impact.”

‍

Behind the award is a deliberate operating system engineered to concentrate and compound talent. Over the past year, Genomenon has sharpened that system by:

• Embedding continuous feedback and coaching so employees always know where they stand, beyond annual reviews.
  
  
• Introducing structured career frameworks and bias-aware performance tools to make growth more transparent and consistent.
  
  
• Reinforcing flexibility and autonomy across its globally distributed workforce in the United States and Bosnia and Herzegovina, while holding a single high bar for performance and impact.
  
  
• Regularly reviewing compensation and promotion systems for bias and training managers to lead inclusively.

‍

Genomenon has also deepened its community and rare disease engagement, pairing awareness campaigns with action through free curated variant insights for researchers, ongoing internship and mentoring programs, and its virtual Summer Camp, which connects employees directly with advocates and families impacted by rare diseases.

‍

“Everyone at Genomenon is an equity stakeholder,” McCann said. “We encourage every team member to act, and feel, like an owner.” That ownership mindset, grounded in empathy and purpose, continues to define how the company grows, connects, and leads.

‍

About Genomenon

‍

Genomenon is a genomic intelligence company transforming patient care by uncovering the genomic drivers of genetic disease and cancer. By combining the power of AI built on a comprehensive genomic dataset with deep scientific expertise, Genomenon delivers structured, actionable insights that support advanced patient diagnosis and accelerate precision medicine development. Its integrated software, data, and services solutions empower biopharma and clinical partners worldwide.

‍

Follow us on LinkedIn for the latest news and updates.